Related Experiment Video
Updated: Apr 25, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Sickle cell disease: new opportunities and challenges in Africa
J Makani1, S F Ofori-Acquah2, O Nnodu3
1Department of Haematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania ; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Insights
Sickle cell disease (SCD) is a major global genetic disorder. This review focuses on SCD in Africa, detailing its molecular basis, epidemiology, diagnosis, and management, especially in resource-limited settings.
Area of Science:
- Genetics
- Hematology
- Public Health
Background:
- Sickle cell disease (SCD) is a prevalent inherited blood disorder globally.
- Africa bears the highest burden of SCD, significantly impacting health outcomes.
- Understanding SCD's molecular and pathophysiological basis is crucial for effective management.
Purpose of the Study:
- To review the epidemiology, molecular basis, and clinical manifestations of SCD in Africa.
- To highlight effective laboratory diagnostic and management strategies for SCD in resource-limited settings.
- To identify research gaps and guide evidence-based healthcare for SCD in Africa.
Main Methods:
- Comprehensive literature review of SCD in Africa.
- Analysis of epidemiological data, including prevalence, morbidity, and mortality.
- Evaluation of diagnostic and management strategies, focusing on resource-limited contexts.
Main Results:
- SCD is a leading cause of genetic illness and mortality worldwide, with Africa disproportionately affected.
- Epidemiological data reveal significant prevalence and mortality rates across the African continent.
- Effective, resource-conscious strategies for SCD diagnosis and management have been identified.
Conclusions:
- SCD poses a substantial public health challenge in Africa.
- Targeted interventions and further research are essential to mitigate the impact of SCD in Africa.
- Evidence-based guidelines are needed to improve healthcare for SCD patients in resource-limited African settings.
Abstract:
Sickle cell disease (SCD) is one of the most common genetic causes of illness and death in the world. This is a review of SCD in Africa, which bears the highest burden of disease. The first section provides an introduction to the molecular basis of SCD and the pathophysiological mechanism of selected clinical events. The second section discusses the epidemiology of the disease (prevalence, morbidity, and mortality), at global level and within Africa. The third section discusses the laboratory diagnosis and management of SCD, emphasizing strategies that been have proven to be effective in areas with limited resources. Throughout the review, specific activities that require evidence to guide healthcare in Africa, as well as strategic areas for further research, will be highlighted.
More Related Videos
Related Concept Videos
Multiple Allele Traits
iPS Cell Differentiation
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

